Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Johan van Meerloo"'
Autor:
Margot Roeten, Suzanne van Dijk, Johan van Meerloo, Zinia Kwidama, Gaya Jenkins, David Teachey, Meenakshi Devidas, Mignon Loh, Gertjan Kaspers, Sonja Zweegman, Gerrit Jansen, Terzah Horton, Jacqueline Cloos
Publikováno v:
HemaSphere, Vol 7, p e81299a0 (2023)
Externí odkaz:
https://doaj.org/article/40d3b42d44514f25bb8ba0bffe07ecbd
Autor:
Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg-Witte, Annoek E.C. Broers, Jaap A. van Doesum, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J.E. Haverkate, Johan van Meerloo, Judith A. Burger, Joey H. Bouhuijs, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sandra Vogels-Nooijen, Nynke Rots, Josine van Beek, Mirjam H.M. Heemskerk, Kazimierz Groen, Tom van Meerten, Pim G.N.J. Mutsaers, Marit J. van Gils, Abraham Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof, Iris M.J. Kant, Thecla Graas, Belle Toussaint, Sterre de Jong, Shahan Darwesh, Sandjiv S. Mahes, Dora Kamminga, Matthijs Koelewijn, Gino Faber, Guus Beaumont, Marije D. Engel, R. Cheyenne N. Pierie, Suzanne R. Janssen, Edith van Dijkman, Jarom Heijmans, Yara Y. Witte, Rogers A. Nahui Palomino, Said Z. Omar, Sonja Zweegman, Arnon P. Kater, Caya van den Vegt, Ilonka Arends-Halbesma, Emma de Pater, Margriet J. Dijkstra, Nynke Y. Rots, Esther Siteur-van Rijnstra, Dennis M. de Rooij, Rogier W. Sanders, Meliawati Poniman, Wouter Olijhoek, Jacqueline van Rijswijk, Tim Beaumont, Lusia Çetinel, Louis Schellekens, Yvonne M. den Hartogh, Jacqueline Cloos, Suzanne S. Weijers, Saïda Tonouh-Aajoud, Selime Avci, Elianne Roelandse-Koop, Willem A. Dik
Publikováno v:
EClinicalMedicine, Vol 61, Iss , Pp 102040- (2023)
Summary: Background: Patients with haematological malignancies have impaired antibody responses to SARS-CoV-2 vaccination. We aimed to investigate whether a fourth mRNA COVID-19 vaccination improved antibody quantity and quality. Methods: In this coh
Externí odkaz:
https://doaj.org/article/b6705aeb989e44eeb7ee10f048616947
Autor:
Margot S.F. Roeten, Johan van Meerloo, Zinia J. Kwidama, Giovanna ter Huizen, Wouter H. Segerink, Sonja Zweegman, Gertjan J.L. Kaspers, Gerrit Jansen, Jacqueline Cloos
Publikováno v:
Cells, Vol 10, Iss 3, p 665 (2021)
At present, 20–30% of children with acute leukemia still relapse from current chemotherapy protocols, underscoring the unmet need for new treatment options, such as proteasome inhibition. Ixazomib (IXA) is an orally available proteasome inhibitor,
Externí odkaz:
https://doaj.org/article/d4a7babdfc8741c2a36eeee2b88bbbb5
Autor:
Denise Niewerth, Gertjan J. L. Kaspers, Gerrit Jansen, Johan van Meerloo, Sonja Zweegman, Gaye Jenkins, James A. Whitlock, Stephen P. Hunger, Xiaomin Lu, Todd A. Alonzo, Peter M. van de Ven, Terzah M. Horton, Jacqueline Cloos
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-9 (2016)
Abstract Background Drug combinations of the proteasome inhibitor bortezomib with cytotoxic chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric acute myeloid leukaemia (AML) and acute lymphocytic leukaemia (AL
Externí odkaz:
https://doaj.org/article/172eb78a2bea491c981a5e1211f1352f
Autor:
Denise Niewerth, Niels E. Franke, Gerrit Jansen, Yehuda G. Assaraf, Johan van Meerloo, Christopher J. Kirk, Jeremiah Degenhardt, Janet Anderl, Aaron D. Schimmer, Sonja Zweegman, Valerie de Haas, Terzah M. Horton, Gertjan J.L. Kaspers, Jacqueline Cloos
Publikováno v:
Haematologica, Vol 98, Iss 12 (2013)
The ex vivo sensitivity of pediatric leukemia cells to the proteasome inhibitor bortezomib was compared to 3 next generation proteasome inhibitors: the epoxyketone-based irreversible proteasome inhibitors carfilzomib, its orally bio-available analog
Externí odkaz:
https://doaj.org/article/c2e0671e06624cadbb28d8bbbeaabb4e
Autor:
Niels W.C.J. van de Donk, Tuna Mutis, A. Kate Sasser, Henk M. Lokhorst, Torben Plesner, Christopher Chiu, Richard W.J. Groen, Pino J. Poddighe, René J.P. Musters, Johan van Meerloo, Sonja Zweegman, Marloes E.C. Broekmans, Andries C. Bloem, Jeroen F. van Velzen, Berris van Kessel, Inger S. Nijhof, Kris A. Frerichs, Jakub Krejcik
Supplemental Methods, Supplementary Tables, Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0452721a8c1ab9f0e419e4de516be385
https://doi.org/10.1158/1078-0432.22462592
https://doi.org/10.1158/1078-0432.22462592
Autor:
Niels W.C.J. van de Donk, Tuna Mutis, A. Kate Sasser, Henk M. Lokhorst, Torben Plesner, Christopher Chiu, Richard W.J. Groen, Pino J. Poddighe, René J.P. Musters, Johan van Meerloo, Sonja Zweegman, Marloes E.C. Broekmans, Andries C. Bloem, Jeroen F. van Velzen, Berris van Kessel, Inger S. Nijhof, Kris A. Frerichs, Jakub Krejcik
Monocytes take up AF488-labeled daratumumab-CD38 complexes from PKH-26-stained UM9 cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::230a4dcac28395ecc5fc3cc16b3eb690
https://doi.org/10.1158/1078-0432.22462577.v1
https://doi.org/10.1158/1078-0432.22462577.v1
Autor:
Niels W.C.J. van de Donk, Tuna Mutis, A. Kate Sasser, Henk M. Lokhorst, Torben Plesner, Christopher Chiu, Richard W.J. Groen, Pino J. Poddighe, René J.P. Musters, Johan van Meerloo, Sonja Zweegman, Marloes E.C. Broekmans, Andries C. Bloem, Jeroen F. van Velzen, Berris van Kessel, Inger S. Nijhof, Kris A. Frerichs, Jakub Krejcik
Daratumumab-mediated CD38 reduction of MM cells in the presence of PBMCs as shown by Western blot analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::058adc8564febc80f981da9e7692cc1e
https://doi.org/10.1158/1078-0432.22462586.v1
https://doi.org/10.1158/1078-0432.22462586.v1
Autor:
Niels W.C.J. van de Donk, Tuna Mutis, A. Kate Sasser, Henk M. Lokhorst, Torben Plesner, Christopher Chiu, Richard W.J. Groen, Pino J. Poddighe, René J.P. Musters, Johan van Meerloo, Sonja Zweegman, Marloes E.C. Broekmans, Andries C. Bloem, Jeroen F. van Velzen, Berris van Kessel, Inger S. Nijhof, Kris A. Frerichs, Jakub Krejcik
Loss of CD38 from the MM cell membrane is associated with reduced CDC and ADCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5a3bd6823c4ef97e445cbca8c50e4be
https://doi.org/10.1158/1078-0432.22462589.v1
https://doi.org/10.1158/1078-0432.22462589.v1
Autor:
Niels W.C.J. van de Donk, Tuna Mutis, A. Kate Sasser, Henk M. Lokhorst, Torben Plesner, Christopher Chiu, Richard W.J. Groen, Pino J. Poddighe, René J.P. Musters, Johan van Meerloo, Sonja Zweegman, Marloes E.C. Broekmans, Andries C. Bloem, Jeroen F. van Velzen, Berris van Kessel, Inger S. Nijhof, Kris A. Frerichs, Jakub Krejcik
Purpose: Daratumumab treatment results in a marked reduction of CD38 expression on multiple myeloma cells. The aim of this study was to investigate the clinical implications and the underlying mechanisms of daratumumab-mediated CD38 reduction.Experim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cc1ec2ca3e37165483ff0af7857d0b2
https://doi.org/10.1158/1078-0432.c.6525140
https://doi.org/10.1158/1078-0432.c.6525140